Literature DB >> 10529630

Characteristic cytokine products of Th1 and Th2 cells in hemodialysis patients.

Y Daichou1, S Kurashige, S Hashimoto, S Suzuki.   

Abstract

Dysfunction of the host defense against infection in hemodialysis (HD) patients has major clinical and socioeconomic implications. T helper type 1 (Th1) and type 2 (Th2) cytokines are implicated in regulating the immune responses and, therefore, may be involved in impaired status. The present study was designed to examine Th1 and Th2 cytokine profiles in 22 stable HD patients (aged 63 +/- 11 years) and 22 healthy controls (aged 60 +/- 6 years). The T cell activity was significantly retarded in HD patients as compared with normal persons. The proportions of T cytotoxic/suppressor cells and natural killer cells were significantly higher in HD patients than in controls. In contrast, the proportions of T helper/inducer and B cells were significantly lower in HD patients than in controls. The production of interleukin (IL) 2, which is involved in cell-mediated immune responses, and the production of IL-4 and IL-10, which affect humoral immunity, were significantly lower in patients than in controls. The production of IL-12 by macrophages and of interferon gamma by Th1 cells was significantly higher in HD patients than in controls. The concentration of plasma sIL-2R was significantly higher in patients than in controls. These results suggest that both cellular immunity induced by Th1 and humoral immunity induced by Th2 decrease in HD patients, but that improved IL-12 secretion by macrophages activated natural killer cells to produce interferon gamma, which in turn induced macrophage activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529630     DOI: 10.1159/000045516

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis.

Authors:  Chen XiaoHong; Shen Bo; Xiang FangFang; Guo Man; Zou JianZhou; Liu ZhongHua; Lv WenLv; Cao XueSen; Ding XiaoQiang; Zhang Boheng
Journal:  Int J Clin Oncol       Date:  2019-06-10       Impact factor: 3.402

2.  Lipoprotein (a) as an acute phase reactant in patients on chronic hemodialysis.

Authors:  Valdete Topciu Shufta; Luljeta Begolli; Emrush Kryeziu
Journal:  Bosn J Basic Med Sci       Date:  2010-02       Impact factor: 3.363

Review 3.  Biology of sepsis: its relevance to pediatric nephrology.

Authors:  Neal B Blatt; Sushant Srinivasan; Theresa Mottes; Maureen M Shanley; Thomas P Shanley
Journal:  Pediatr Nephrol       Date:  2014-01-10       Impact factor: 3.714

4.  The significance of serum levels of soluble interleukin-2 receptor in patients undergoing maintenance hemodialysis.

Authors:  Xiaohong Chen; Yang Li; Xiaoqiang Ding; Jianzhou Zou; Bo Shen; Zhonghua Liu; Wenlv Lv; Xuesen Cao; Fangfang Xiang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

5.  Immunological Alterations due to Hemodialysis Might Interfere with Early Complications in Renal Transplantation.

Authors:  Kristin Mai; Andreas Boldt; Hans-Michael Hau; Michael Kirschfink; Stephan Schiekofer; Frieder Keller; Joachim Beige; Athanassios Giannis; Ulrich Sack; Franz Maximilian Rasche
Journal:  Anal Cell Pathol (Amst)       Date:  2019-03-25       Impact factor: 2.916

6.  Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients.

Authors:  Serkan Ocal; Haldun Selcuk; Murat Korkmaz; Reskan Altun; Abdullah E Yildirim; Enver Akbas
Journal:  Saudi J Gastroenterol       Date:  2014 May-Jun       Impact factor: 2.485

7.  Potential role of the soluble form of CD40 in deficient immunological function of dialysis patients: new findings of its amelioration using polymethylmethacrylate (PMMA) membrane.

Authors:  Cécile Contin-Bordes; Adeline Lacraz; Valérie de Précigout
Journal:  NDT Plus       Date:  2010-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.